0.5921
price up icon10.20%   0.0556
 
loading

Finanzdaten der Bioatla Inc-Aktie (BCAB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - 11.00 -
Operating Expenses
5.86%
18.65
17.61 16.24 22.27 21.97
Operating Income/Loss
5.86%
-18.65
-17.61 -16.24 -11.27 -21.97
Income/Loss From Continuing Operations Before Tax
22.02%
-18.71
-15.33 -14.88 -10.59 -21.07
Income/Loss From Continuing Operations After Tax
22.02%
-18.71
-15.33 -14.88 -10.59 -21.07
Net Income/Loss
22.02%
-18.71
-15.33 -14.88 -10.59 -21.07
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.44%
58.50
58.25 0.3602 48.34 48.21
Diluted Average Shares
0.44%
58.50
58.25 0.3602 48.34 48.21
Basic Earnings Per Share
23.08%
-0.32
-0.26 -0.30 -0.22 -0.44
Diluted Earnings Per Share
23.08%
-0.32
-0.26 -0.30 -0.22 -0.44
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.27
price down icon 14.24%
$86.42
price up icon 0.06%
$27.38
price down icon 0.64%
$108.26
price down icon 2.97%
$145.64
price up icon 0.41%
biotechnology ONC
$341.94
price up icon 0.16%
Kapitalisierung:     |  Volumen (24h):